If one was following the price action of stocks today in response to Trump’s Thursday announcement of steel and aluminum import tariffs, one would be left with the impression that either the market thinks Trumps is bluffing, or that tariffs
March 2, 2018
WEST LAFAYETTE, March 02, 2018 (GLOBE NEWSWIRE) — Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, announced today the closing of an underwritten registered public offering of 20,535,714 shares of its common stock, including full